Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC)

Clinical trial NCT07093489 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07093489
Sponsor: International Vaccine Institute
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Mpox (Monkeypox)Mpox

Start date: 2025-09-30
Primary completion: 2027-08-01
Enrollment: 11990

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.